Purchase Order 36C24423P0360

Award Date 5/1/23
Potential Completion Date 4/30/24
Potential Value $664K
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Aspinwall, PA 15215, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), part of the U.S. Department of Veterans Affairs (VA), to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of emergency radiopharmaceuticals, with a ceiling value of $94,702.70 and a completion date of April 15, 2022. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and...
This is a federal contract award to Sofie CO., doing business as Sofie, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1). The contract is for the supply of radiopharmaceuticals, valued at $173,674.50, to support medical imaging and cancer treatment programs for veterans. The contract has a firm fixed price and runs from April 1, 2016, to September 30, 2017. There was no set-aside designation used for this award. In addition to this contract, Sofie holds...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., provides PET/CT radiopharmaceuticals to the Department of Veterans Affairs (VA). The $2,343,583.08 fixed-price contract was set aside for small businesses and is scheduled for completion by September 30, 2023. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with extensive experience in positron emission tomography (PET) imaging. The company has been a key provider of...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
This is a $1,916,610.00 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of FDG and NEURACEQ radiopharmaceuticals, which are critical medical imaging products used for cancer detection and Alzheimer's disease diagnostics. Sofie Biosciences, Inc. is a specialized manufacturer of molecular diagnostics and therapeutics, with a...
This is a federal contract award to Sofie CO., doing business as Sofie, a for-profit organization specializing in the development and delivery of molecular diagnostics and therapeutics. The $80,750 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) to provide PET (Positron Emission Tomography) pharmaceuticals. The contract is part of the VA's VISN 4 (Veterans Integrated Service Network 4) program and has an ultimate completion date of December 30, 2019. Sofie has...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...

This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense Health Agency (DHA), and the National Institutes of Health (NIH). The contract has an ultimate completion date of April 30, 2024 and was awarded on May 1, 2023 without a set-aside designation, reflecting Sofie's established position as a specialized supplier in this field. The contract is part of Sofie's larger Indefinite Delivery Vehicle (IDV) and Blanket Purchase Agreement (BPA) contracts with the VA and DHA, valued at $5.86 million, $1.7 million, and $1.5 million respectively, which facilitate the ongoing supply of radiopharmaceuticals and related services to various federal healthcare facilities.

Generated 8/20/24, 9:38 AM